KARYOPHARM THERAPEUTICS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 25K for the last quarter is 34.83 M EUR, and it's 12.80% lower compared to the previous quarter. The net income of Q3 24 is -28.81 M EUR.